PROSPECTIVE, RANDOMIZED, PLACEBO-CONTROLLED PHASE 2 TRIAL OF ASPIRIN FOR VESTIBULAR SCHWANNOMAS

$1,493,355FY2017Defense Health AgencyDOD

Massachusetts Eye And Ear Infirmary, Boston MA

Investigators